Amyloid Complete
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 40% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
3 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
40%
Evidence Coverage
Supplement Facts — Evidence Check
900 mg
📊 Market median: 800.0mg (172 products)
📊 Market median: 450.0mg (254 products)
📚 240 studies (Tier A: 0, B: 100)
Shoden
160 mg
150 mg
📊 Market median: 250.0mg (182 products)
📚 10 studies (Tier A: 0, B: 2)
Palmfruit Bioactive Complex
100 mg
Other Ingredients
Hypromellose
Microcrystalline Cellulose
Leucine
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (99% of products)
Structure/Function (84% of products)
Nutrient (26% of products)
No Claim (1% of products)
Target Groups
Vegetarian
Adult (18 - 50 Years)
Gluten Free
Product Information
📋 Directions for Use
Suggested Use: As a dietary supplement, take 3 capsules daily, or as directed by your healthcare practitioner.
⚠️ Warnings & Precautions
Warning: If pregnant or nursing, consult your healthcare practitioner before taking this product.
Caution: Discontinue use 2 weeks prior to surgery.
Keep out of reach of children.
Contains: Milk.
To obtain product information or report a serious adverse event, call 1-800-325-1776.
🧪 Formulation Notes
Color of this product may vary due to color variations of the natural ingredients.
A Dietary Supplement to support healthy cognitive function in the aging brain
Vegetarian
Gluten free Soy free
Additional Information
Store in a cool, dry place.
Product Details
UPC / SKU
0 26664 01505 1
DSLD Entry Date
2024-06-20
Product Type
Other Combinations
Form
Capsule
Brand
DaVinci Laboratories
DSLD ID
313206
Data Updated
2026-04-11
Research Evidence
19
Research Sources
52
Avg Quality Score
8
Clinical Trial
4
Cochrane Review
2
Systematic Review
2
Meta Analysis
2
Guideline
1
Rct
B
[Expert consensus on the application of intravenous immunoglobulin in children with autoimmune neurological disorders (2025)].
B
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).
B
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barré syndrome.
B
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
B
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
B
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
C
Intravenous immunoglobulin for myasthenia gravis
C
Impact of Selenium Supplementation in Neutropenia and Immunoglobulin Production in Childhood Cancer Patients
C
Breast-Milk Iodine Concentrations and Iodine Levels of Infants According to the Iodine Status of the Country of Residence: A Systematic Review and Meta-Analysis
Compare Similar Products
Mother's Gift Colostrum
Roex
100
Amyloid Benefits
DaVinci Benefits Line
100
Colostrum ImmunDefense
Wonder Laboratories
100
GALT-immune
Energetix
100
Colostrum ImmuFend
DC
100